News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Supreme Court struck down major emergency tariff authority, prompting administration to set a temporary 15% global tariff and raising trade uncertainty.
  • Morgan Stanley upgraded Unimicron and Nan Ya PCB to Overweight, citing multi-year AI-driven growth and tightening ABF substrate supply.
  • Analysts expect Nvidia to report a strong quarter, driven by Blackwell GPUs and H200 shipments lifting AI data-center demand.
  • A circulated AI disruption scenario triggered selloffs in DoorDash, software and payments stocks, pressuring tech and platform sectors.
  • Fitch downgraded Bahrain to B, citing rising government debt and signaling increased sovereign credit stress in Gulf markets.
  • Volvo will recall 40,323 EX30 EVs to replace overheating battery packs and asks owners to cap charging at 70% pending replacements.
  • ARKO Petroleum completed a $200 million IPO, with parent ARKO Corp. retaining majority economic interest and voting control.

Latest Articles

Knesset set for opening vote on 2026 budget as coalition strains threaten stability

Knesset set for opening vote on 2026 budget as coalition strains threaten stability

Israel’s parliament moves to cast an initial vote on the 2026 state budget draft amid deepening rifts within Prime Minister Benjamin Netanyahu’s coalition. With the law requiring full approval by the end of March or a snap election being triggered, disputes over military conscription for ultra-Orthodox seminary students and sharp differences over w…

Eli Lilly secures up to $1.12 billion agreement with Seamless Therapeutics to pursue gene-editing treatments for hearing loss

Eli Lilly secures up to $1.12 billion agreement with Seamless Therapeutics to pursue gene-editing treatments for hearing loss

Eli Lilly has entered into a collaboration worth as much as $1.12 billion with Germany-based Seamless Therapeutics to develop and commercialize gene-editing therapies aimed at certain forms of hearing loss. The arrangement grants Lilly access to Seamless' proprietary enzyme platform, which engineers programmable recombinases designed to make large,…

UBS Downgrades Intershop to Neutral, Citing Limited Upside After Rally

UBS Downgrades Intershop to Neutral, Citing Limited Upside After Rally

UBS moved Intershop Holding AG (SIX:ISN) from a 'buy' to a 'neutral' rating while increasing its 12-month price target to CHF170. The brokerage says the stock's strong run has restored its valuation to historical norms, leaving scant upside from recent levels. UBS also trimmed revenue and adjusted EPS forecasts for fiscal 2025-27 and highlighted ti…

Dollar Pauses After Sharp Slide as Policy Signals and Market Moves Collide

Dollar Pauses After Sharp Slide as Policy Signals and Market Moves Collide

The dollar steadied on Wednesday following a steep decline to a four-year low overnight, a move that President Donald Trump publicly welcomed as the currency being "great" and that it should "just seek its own level." Markets are weighing whether the administration prefers a weaker dollar while Treasury Secretary Scott Bessent has remained tight-li…

Eikon Therapeutics Seeks $908.2 Million Valuation in U.S. IPO

Eikon Therapeutics Seeks $908.2 Million Valuation in U.S. IPO

On Jan. 28, Eikon Therapeutics filed to pursue a U.S. initial public offering that would value the company at as much as $908.2 million and raise up to $317.7 million by selling 17.65 million shares at $16 to $18 apiece. The Millbrae, California-based drug developer is advancing a cancer pipeline led by EIK1001, being evaluated in combination with …

London Stocks Slip as Healthcare and Banks Weigh on FTSE 100

London Stocks Slip as Healthcare and Banks Weigh on FTSE 100

On Jan 28 the FTSE 100 declined as losses in healthcare and bank shares offset gains in miners and energy names. The domestically focused FTSE 250 rose, hitting its highest level since January 2022 earlier in the session. Market attention centred on corporate earnings and an awaited U.S. Federal Reserve policy update.

RLAY Trade Setup: Upgrade Heat Meets a High-Short-Interest Tape

RLAY Trade Setup: Upgrade Heat Meets a High-Short-Interest Tape

Relay Therapeutics is catching a bid as optimism builds around zovegalisib (RLY-2608). With shares back near the top of the 52-week range and short interest still heavy, the next move likely comes down to whether price can hold above key moving averages and push through recent resistance. Here’s a defined long trade with a tight invalidation level …

AT&T Lays Infrastructure Bets, Sees 2026 Profit Above Street Estimates

AT&T Lays Infrastructure Bets, Sees 2026 Profit Above Street Estimates

AT&T said it expects 2026 adjusted earnings per share to exceed analyst forecasts, attributing the upbeat outlook to planned network investments including the acquisition of Lumen’s consumer fiber assets and EchoStar’s spectrum licenses. The company reported healthy fiber and wireless additions in the fourth quarter and will consolidate 5G and fibe…

China’s Wang Yi Tells France China and EU Are Partners, Not Rivals

China’s Wang Yi Tells France China and EU Are Partners, Not Rivals

China’s Foreign Minister Wang Yi told Emmanuel Bonne, the diplomatic adviser to the French president, that China and the European Union are partners rather than rivals during a telephone conversation on Wednesday. Wang said Beijing and the EU share positions on promoting a multipolar world, advocated resolving trade disputes through dialogue, and u…

Stellantis Deepens Price Cuts in France to Drive Volume Recovery

Stellantis Deepens Price Cuts in France to Drive Volume Recovery

Stellantis said it will step up price reductions on new cars in France, accelerating a program that began in late 2025. The move, announced by the head of Stellantis France, aims to rebuild vehicle sales volumes in the company's largest European market, with discounts already applied to several small car models.